Guidant Gets FDA Approval for Pacing Lead Products - TheStreet

Guidant

(GDT)

received approval from the

Food and Drug Administration

to market a new pacing lead group of products.

Pacing lead systems connect pacemakers to the heart. Guidant, a medical device maker based in Indianapolis, expects to launch the Fineline II Sterox group in the U.S. in February.

Shares of Guidant recently rose $1.69, or 3.2%, to $54.88 in

New York Stock Exchange

trading.